PTGS2 and non-small cell lung carcinoma: Notably, a single nucleotide polymorphism in the COX-2 promoter region, a change of -1195 G to A (-1195 G/A SNP) that leads to increases in enzymatic activity, is associated with poor survival and poor progression-free survival in unresectable locally advanced NSCLC [8].